Decision rule based multiplicity adjustment strategy.

Area of Science:

• Biostatistics
• Clinical Trial Design
• Statistical Inference

Background:

• Determining the need for multiplicity adjustment in clinical trials can be complex and lead to controversy.
• Existing methods may not adequately address the logical relationships between multiple hypotheses.
• Controlling the Type I error rate is crucial for the validity of clinical trial results.

Purpose of the Study:

• To propose a novel decision rule-based multiplicity adjustment strategy.
• To link hypotheses by their logical relationships and group them into families.
• To maintain strong control of the Type I error rate within each defined family.

Main Methods:

• Development of a multiplicity adjustment strategy based on a predefined clinical trial decision rule.
• Grouping of multiple hypotheses into distinct families according to logical relationships.
• Application of the proposed strategy to a real-world clinical trial dataset.

Main Results:

• The proposed strategy effectively minimizes potential controversies in multiplicity adjustment.
• Demonstrated application to a raloxifene clinical trial shows practical utility.
• Maintained strong control of Type I error rates within hypothesis families.

Conclusions:

• The decision rule-based multiplicity adjustment strategy offers a robust approach to managing multiple comparisons.
• This method enhances the reliability and interpretability of clinical trial findings.
• The strategy provides a structured framework for hypothesis testing in complex trial designs.